Inventor
GHOSH SHOMIR
US72 patents
⚠️ This page may combine multiple inventors who share the name “GHOSH SHOMIR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNATE TUMOR IMMUNITY INC
10 patentsUS10556903B2Feb 11, 2020
NLRP3 modulators
INNATE TUMOR IMMUNITY INC12 citations85
US10604542B2Mar 31, 2020
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
INNATE TUMOR IMMUNITY INC5 citations83
US10533005B2Jan 14, 2020
NLRP3 modulators
INNATE TUMOR IMMUNITY INC9 citations83
US11344543B2May 31, 2022
NLRP3 modulators
INNATE TUMOR IMMUNITY INC2 citations72
US10961270B2Mar 30, 2021
Compounds and compositions for treating conditions associated with sting activity
INNATE TUMOR IMMUNITY INC2 citations72
US12351580B2Jul 8, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US12171756B2Dec 24, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US11827632B2Nov 28, 2023
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US11505571B2Nov 22, 2022
Compounds and compositions for treating conditions associated with sting activity
INNATE TUMOR IMMUNITY INC0 citations62
US11072612B2Jul 27, 2021
NLRP3 modulators
INNATE TUMOR IMMUNITY INC1 citations62
MILLENNIUM PHARM INC
8 patentsUS7880002B2Feb 1, 2011
Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
MILLENNIUM PHARM INC10 citations84
US7329755B2Feb 12, 2008
CCR8 inhibitors
MILLENNIUM PHARM INC11 citations82
US7211672B2May 1, 2007
PGD2 receptor antagonists for the treatment of inflammatory diseases
MILLENNIUM PHARM INC12 citations82
US7951950B2May 31, 2011
PGD2 receptor antagonists for the treatment of inflammatory diseases
MILLENNIUM PHARM INC14 citations81
US7504508B2Mar 17, 2009
PGD2 receptor antagonists for the treatment of inflammatory diseases
MILLENNIUM PHARM INC14 citations80
US7977350B2Jul 12, 2011
CCR1 antagonists and methods of use therefor
MILLENNIUM PHARM INC5 citations74
US7732459B2Jun 8, 2010
CCR1 antagonists and methods of use therefor
MILLENNIUM PHARM INC4 citations74
US7541365B2Jun 2, 2009
Chemokine receptor antagonists and methods of use therefor
MILLENNIUM PHARM INC6 citations73
NOVARTIS AG
6 patentsUS11724992B2Aug 15, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG1 citations71
US11203579B2Dec 21, 2021
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG2 citations71
US12421223B2Sep 23, 2025
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US11760735B2Sep 19, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US11597706B2Mar 7, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US11339136B2May 24, 2022
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
SINGH JUSWINDER
5 patentsUS8586600B2Nov 19, 2013
Heterocyclic compounds and uses thereof
SINGH JUSWINDER6 citations84
US8445498B2May 21, 2013
4,6-disubstituted pyrimidines useful as kinase inhibitors
SINGH JUSWINDER8 citations84
US8329901B2Dec 11, 2012
4,6-disubstitued pyrimidines useful as kinase inhibitors
SINGH JUSWINDER11 citations84
US8242271B2Aug 14, 2012
Heterocyclic compounds and uses thereof
SINGH JUSWINDER9 citations84
US9556426B2Jan 31, 2017
Protein kinase conjugates and inhibitors
SINGH JUSWINDER3 citations71
CELGENE AVILOMICS RES INC
4 patentsUS9040541B2May 26, 2015
4,6-disubstituted pyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC5 citations84
US8748606B2Jun 10, 2014
4,6-diaminopyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC8 citations84
US9393246B2Jul 19, 2016
4,6-disubstituted pyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC3 citations73
US9067929B2Jun 30, 2015
Heterocyclic compounds and uses thereof
CELGENE AVILOMICS RES INC4 citations73
GILEAD APOLLO LLC
4 patentsUS10800791B2Oct 13, 2020
Triazole ACC inhibitors and uses thereof
GILEAD APOLLO LLC3 citations73
US10179793B2Jan 15, 2019
ACC inhibitors and uses thereof
GILEAD APOLLO LLC7 citations73
US11098055B2Aug 24, 2021
Ester ACC inhibitors and uses thereof
GILEAD APOLLO LLC0 citations62
US10941158B2Mar 9, 2021
Pyrazole ACC inhibitors and uses thereof
GILEAD APOLLO LLC0 citations62
PETTER RUSSELL C
2 patentsAVILA THERAPEUTICS INC
2 patentsBALOGLU ERKAN
2 patentsCARSON KENNETH G
2 patentsCHIANG PHOEBE
1 patentKYOWA HAKKO KOGYO KK
1 patentInnate Tumor Immunity
1 patentLULY JAY R
1 patentNOVARTIS INFLAMMASOME RES INC
1 patentShowing the top 50 of 72 patents by PatentIndex Score.